Your browser doesn't support javascript.
loading
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3ß signalling pathway in renal cell carcinoma.
Zhu, Qian; Zhong, Ai-Lin; Hu, Hao; Zhao, Jing-Jing; Weng, De-Sheng; Tang, Yan; Pan, Qiu-Zhong; Zhou, Zi-Qi; Song, Meng-Jia; Yang, Jie-Ying; He, Jun-Yi; Liu, Yuan; Li, Min; Hu, Wan-Ming; Yang, Chao-Pin; Xiang, Tong; Chen, Ming-Yuan; Ma, Gang; Guo, Ling; Xia, Jian-Chuan.
Afiliação
  • Zhu Q; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhong AL; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Hu H; Office of International Exchange and Cooperation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, People's Republic of China.
  • Zhao JJ; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, 330006, People's Republic of China.
  • Weng DS; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Tang Y; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Pan QZ; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhou ZQ; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Song MJ; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Yang JY; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • He JY; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu Y; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Li M; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Hu WM; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Yang CP; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Xiang T; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Chen MY; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Ma G; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
  • Guo L; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Xia JC; Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
J Hematol Oncol ; 16(1): 110, 2023 Nov 04.
Article em En | MEDLINE | ID: mdl-37925485

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China